Benefits of Iodoform Packing Strip
Iodoform packing strips provide effective antiseptic properties, facilitate necrotic tissue removal through fibrinolytic activity, and promote wound healing in surgical cavities and infected wounds, though evidence for routine use in all wound types remains limited.
Primary Benefits
Antiseptic and Antimicrobial Action
Iodoform formulations serve as healing aids for infected wounds and surgical cavities 1. The antiseptic properties of iodine-based products are well-established, with evidence showing they do not impair wound healing or cause delays in the healing process 2. In chronic and burn wounds specifically, iodine demonstrates effective antiseptic action comparable to other modern agents 2.
Necrotic Tissue Debridement
The most compelling evidence for iodoform use is its unique fibrinolytic activity. Biochemical studies demonstrate that iodoform gauze efficiently removes necrotic tissue by lysing collagen fibers 3. Clinical observations show that more than 60% of iodoform gauze-treated wounds achieved complete debridement within 2 weeks, significantly outperforming conventional ointments 3. This occurs through the release of non-aggregative type I collagen from necrotic debris, effectively breaking down macroaggregates that comprise necrotic tissue 3.
Application in Jaw Lesions
A systematic review of 92 studies involving 386 patients found iodoform-based dressings (particularly BIPP formulations) relatively safe and effective for managing extensive jaw lesions requiring secondary healing 4. These were most commonly used following surgical treatment of ameloblastoma and odontogenic keratocysts, with weekly gauze pack changes until complete cavity healing 4.
Clinical Context and Limitations
Wound Healing Outcomes
The evidence on healing time is mixed. While iodoform shows superior debridement, comparative studies indicate:
- Silver dressings significantly reduce healing time compared to iodine dressings (SMD=-0.95, moderate-quality evidence) 5
- Iodine does not prolong wound healing compared to other antiseptic dressings 2
- No significant difference exists in overall healing rates between silver and iodine dressings 5
Infection Prevention
For surgical site infection prevention, the evidence is equivocal. Povidone-iodine impregnated dressings showed zero infections versus 25% infection rate with standard dressings in one small surgical wound study 6. However, more recent evidence suggests PV-I is not highly recommended as a surface disinfectant for routine wound care, with chlorhexidine and silver dressings showing more favorable outcomes in certain contexts 7.
Safety Profile
Iodoform is relatively safe with minimal toxicity reported - only 2 of 92 studies in the jaw lesion review documented adverse effects 4. Importantly, thyroid function derailment and other purported harmful effects do not occur more frequently with iodine use 2. However, clinicians should monitor for redness, irritation, or swelling that persists or increases 1.
Practical Application Algorithm
Use iodoform packing when:
- Managing surgical cavities requiring secondary healing (ameloblastoma, keratocysts, large jaw lesions)
- Necrotic tissue requires debridement in infected wounds
- Weekly dressing changes are feasible for patient compliance
Consider alternatives when:
- Rapid healing time is the primary goal (favor silver dressings)
- Routine surgical site infection prevention is needed (consider chlorhexidine)
- Patient compliance with weekly changes is questionable
Avoid or use cautiously:
- In patients with known iodine sensitivity
- When autotransfusion is planned (as with other topical hemostatic agents) 8, 9
Common Pitfalls
The major caveat is that wound packing after abscess drainage remains controversial. A Cochrane review found it unclear whether packing influences healing time, pain, fistula development, or recurrence 10. A subsequent observational study of 141 patients concluded packing is costly, painful, and does not add benefit to healing 10. Therefore, the decision to use iodoform packing should be reserved for specific indications (large surgical cavities, significant necrotic tissue) rather than routine abscess drainage.
The evidence base consists primarily of observational studies and case series rather than high-quality RCTs, particularly for iodoform specifically versus other iodine formulations 4. Prospective randomized trials are needed to definitively establish optimal formulations and treatment duration.